Mark Lampert, Biotechnology Value Fund Up Stake In Cytokinetics, Inc. (CYTK), Reduce Exposure To Regado Biosciences Inc (RGDO)

Mark Lampert, the founder and manager of Biotechnology Value Fund, is bullish on Cytokinetics, Inc. (NASDAQ:CYTK). According to a recent filing with the Securities and Exchange Commission, Lampert has increased his fund’s stake from 1.79 million to 3.28 million shares, which include some 921,100 shares which can be issued upon the exercise of certain warrants. The fund’s current position accounts for 9.98% of the company’s common stock.

In another filing with the SEC, Biotechnology Value Fund has revealed a reduction in its holding of Regado Biosciences Inc (NASDAQ:RGDO) by 1.32 million shares that were disposed of, leaving the fund with 2.33 million shares which account for 9.99% of the company’s common stock.

Cytokinetics, Inc. (NASDAQ:CYTK)

Cytokinetics, Inc. (NASDAQ:CYTK) has also attracted the attention of Paul Ruddock and Steve Heinz, the managers of Lansdowne Partners. According to the fund’s latest 13F report, it holds 2.02 million shares valued at $13.1 million, the position suffering no changes in the previous quarter. Jim Simmons is also bullish on this stock, having initiated a position during the fourth quarter of 2013. Renaissance Technologies reported the ownership of 335,300 shares worth $2.17 million in its latest 13F filing. Israel Englander, the manager of Millennium Management, has decided to limit his exposure to Cytokinetics and has decreased his fund’s position by 36% to 554,700 shares valued at $3.6 million.

Cytokinetics, Inc. (NASDAQ:CYTK) engages in the research and design of small molecule therapeutics. The stock has a market cap of $326 million and does not pay a dividend. The stock has entered an uptrend at the end of 2013 and has advanced 38% so far this year to a current price of $8.95 per share. For the three months ending December 31, 2014, Cytokinetics posted revenues of $24.35 million and earnings per share of $0.22, up from a loss of $0.48 per share reported for the same period in 2012. Analysts expect the company to register $7.69 million in revenues and a loss per share of $0.35 during the current quarter.

Regado Biosciences Inc (NASDAQ:RGDO)

Only two hedge funds that we track have invested in Regado Biosciences Inc (NASDAQ:RGDO), one of them being Wexford Capital run by Charles Davidson. According to the fund’s latest 13F report, during the previous quarter, it has decreased its holding of the stock by 9% to 324,200 shares valued at $1.54 million. Alyeska Investment Group and its manager, Anand Parekh, are actually bullish and have increased their holding by 76% to 116,000 shares reportedly worth $553,000.

A developer of antithrombotic drug systems, Regado Biosciences Inc (NASDAQ:RGDO) has a market cap of $303 million and does not pay a dividend. The stock has been in an uptrend since the start of the year and has advanced 145% to a current price of $12 per share. For the year ending December 31, 2013, the company posted a net loss of $34.4 million, which translated into a loss per share of $4.59.

Disclosure: none.

Recommended reading:

CST Brands Inc (CST): Another Spin-Off Favored by Hedge Funds

Hedge Funds Go Crazy for Carter’s, Inc. (CRI)

Park West Asset Management Boosts Passive Stake In Move Inc. (MOVE)

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Biggest Airports in the World

The 5 Most Gang Infested Cities In America

The 34 Smartest Countries in the World

The 10 Countries with the Highest Suicide Rates

The 10 Most Technologically Advanced Countries in the World

The 10 Safest Countries in the World to Live in Peace

The 10 Top Selling Smartphones in the World 2014

The 12 Biggest Shopping Centers in the World

The 10 Friendliest Countries in the World

Qihoo 360 Technology Co Ltd (QIHU), Actavis plc (ACT), Yahoo! Inc. (YHOO) Among 20 Long Ideas from Sohn Canada

The 10 Laziest Countries in the World

The 10 Most Polluted Countries in the World

The 10 Most Dangerous Cities in America 2014

The Top 10 Gold Producing Countries in the World

The 10 Tallest Buildings in the World

The 10 Richest Stand Up Comedians in the World

The 10 Fattest Countries in the World

The 5 Best Summer Jobs for Teens

The 10 Most Religious Countries in the World Keeping the Faith

The 10 Most Educated Countries in the World

The 10 Most Popular Cell Phones in the World

The 10 Drunkest Countries in the World

The 10 Most Expensive Private Schools in the World

The 10 Smallest Countries in the World

Walking Dead Season 5 Spoilers You’ll Wish You Didn’t Know

The 10 Poorest Countries in the World

The 10 Greenest Countries in the World

The Top 10 Countries with the Highest Population in the World

The 10 Most Visited Countries in the World

The Top 10 Star Wars Characters in the Iconic Series

The 10 Most Expensive Android Phones in the World

5 Reasons Why The Illuminati Is Real and a Threat to Society

The 6 Scariest Halloween Costumes Ever Screamed At

The 4 Biggest Hedge Fund Managers in the World Today

The 15 Most Densely Populated Countries in the World

The 10 Biggest Tea Drinking Countries in the World

Top 6 Ways to Improve Your Checkout Process and Close Sales

The 5 Most Profitable Online Businesses You Can Start Today

The 20 Most Profitable Hospitals in the US

The 5 Most Profitable Home Businesses to Start

The 7 Teams that Will Win the Stanley Cup in 2015

The Top 10 Most Expensive Digital Cameras to Snap Stunning Shots With

The 10 Highest Quality Fast Food Restaurants In America Today

The 8 Best Halloween Decorating Ideas to Spook Up Your House

10 Marvel Women that Should Get a Movie Right Now

The 20 Best Remixes of Popular Songs that Will Make You Forget the Originals

7 Most Expensive Cities in the World

5 Least Expensive Cities in the World

10 Celebrities Who Believe In Scientology

10 High Margin Food Products to Build a Business Around

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!